Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midazolam versus dexmedetomidine for comfort treatment in oral outpatient surgery
ChiCTR1900021516Phase 4Recruiting
- Sponsor
- Hospital of Stomatology Wuhan University
- Start
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of midazolam and dexmedetomidine in Maxillofacial Disorders (2 arms), sponsored by Hospital of Stomatology Wuhan University. Primary endpoint: Ramsay sedation score. Started Feb 2019; status: recruiting.
02
Drugs
midazolamdexmedetomidine
03
Conditions
Maxillofacial Disorders
Beyond the preview
Go deeper on ChiCTR1900021516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900021516.